Literature DB >> 25323580

Methodological comments: McFarlane et al.

Helena Chmura Kraemer1.   

Abstract

Does the McFarlane et al study provide a model for practical trials? Unfortunately, not. The methodological problems are here reviewed and used as a springboard to set out methodological criteria that might define such a model.
© The Author 2014. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Keywords:  criteria; methodology; practical trials

Mesh：

Substances：

Year:  2014        PMID： 25323580      PMCID： PMC4266303          DOI： 10.1093/schbul/sbu139

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN： 0586-7614            Impact factor:   9.306


  10 in total

Review 1.  How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors.

Authors:  H C Kraemer; E Stice; A Kazdin; D Offord; D Kupfer
Journal:  Am J Psychiatry       Date:  2001-06       Impact factor: 18.112

Review 2.  Mediators and moderators of treatment effects in randomized clinical trials.

Authors:  Helena Chmura Kraemer; G Terence Wilson; Christopher G Fairburn; W Stewart Agras
Journal:  Arch Gen Psychiatry       Date:  2002-10

3.  Moderators of treatment outcomes: clinical, research, and policy importance.

Authors:  Helena C Kraemer; Ellen Frank; David J Kupfer
Journal:  JAMA       Date:  2006-09-13       Impact factor: 56.272

Review 4.  The use of propensity score methods in psychiatric research.

Authors:  Tyler VanderWeele
Journal:  Int J Methods Psychiatr Res       Date:  2006-06       Impact factor: 4.035

5.  Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach.

Authors:  Helena Chmura Kraemer
Journal:  Stat Med       Date:  2013-01-10       Impact factor: 2.373

6.  Equipoise and the ethics of clinical research.

Authors:  B Freedman
Journal:  N Engl J Med       Date:  1987-07-16       Impact factor: 91.245

7.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Authors:  Jeffrey A Lieberman; T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Sonia M Davis; Clarence E Davis; Barry D Lebowitz; Joanne Severe; John K Hsiao
Journal:  N Engl J Med       Date:  2005-09-19       Impact factor: 91.245

8.  On the use of propensity scores in principal causal effect estimation.

Authors:  Booil Jo; Elizabeth A Stuart
Journal:  Stat Med       Date:  2009-10-15       Impact factor: 2.373

9.  Clinical and functional outcomes after 2 years in the early detection and intervention for the prevention of psychosis multisite effectiveness trial.

Authors:  William R McFarlane; Bruce Levin; Lori Travis; F Lee Lucas; Sarah Lynch; Mary Verdi; Deanna Williams; Steven Adelsheim; Roderick Calkins; Cameron S Carter; Barbara Cornblatt; Stephan F Taylor; Andrea M Auther; Bentson McFarland; Ryan Melton; Margaret Migliorati; Tara Niendam; J Daniel Ragland; Tamara Sale; Melina Salvador; Elizabeth Spring
Journal:  Schizophr Bull       Date:  2014-07-26       Impact factor: 9.306

10.  A novel approach for developing and interpreting treatment moderator profiles in randomized clinical trials.

Authors:  Meredith L Wallace; Ellen Frank; Helena C Kraemer
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 25.911
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.